Shanghai Tianhe participated in 2017 World Pharmaceutical Raw Materials Southeast Asia Exhibition CPHI Indonesia Exhibition
Exhibition time: March 22-24, 2017
Venue: Jakarta International Convention and Exhibition Center, Indonesia
With the rapid development of the ASEAN market, the scale of trade in pharmaceutical products between China and ASEAN is increasing day by day. ASEAN has become the second largest market for China's medical and health products export. 2017 International Exhibition of Pharmaceutical Raw Materials, Pharmaceutical Machinery and Packaging Materials will be held again in Jakarta, Indonesia. As the largest and most influential exhibition in the field of pharmaceutical raw materials, it will once again gather the focus of the industry. 2012 International Pharmaceutical Raw Materials Exhibition was held for the first time in Indonesia - Jakarta, attracting a large number of enterprises to actively participate in. High-quality visitors: hundreds of key decision makers and buyers of pharmaceutical companies gather here to look for opportunities to purchase pharmaceutical materials, packaging and equipment in large quantities, as well as international partners who can establish long-term and stable relationships.
Scope of Exhibits:
Pharmaceutical raw materials, intermediates, and active ingredients, amino acids, antibiotic, antibacterial, antiseptic, hormones and synthetic products, capsule, animal and plant extracts, catalyst, bulk pharmaceutical raw materials, emulsifying agent, melting agent, herbal tea, intermediates, fine chemicals, colloid, medicinal plants, serum and vaccine, suppository and tablet, medicine, packaging materials and pharmaceutical equipment.
There are several categories of products on display in Tianhe participating exhibition hall:
Stretching across the equator, Indonesia has a population of 258 million and more than 100 ethnic groups in 2015. It is the fourth most populous country in the world and has a huge consumption base. At the same time, Indonesia is also a maritime hub connecting two continents and two oceans. It is one of the fastest growing economies in South Asia. As the main export area of China's pharmaceutical raw materials and pharmaceutical machinery, Southeast Asia has a huge development potential and a very broad market.
In 2014, Indonesia officially launched a universal health care program, JKN. The demand for health care in Indonesia is expected to increase by 50-100% and double in the next five years, creating more investment in this sector. On the other hand, Indonesia imports most of its raw materials from abroad, and China is an important source of other raw materials.
At present, Indonesia relies on the import of more than 1,300 pharmaceutical raw materials (75% from China). In recent
years, the trade volume of medical and health products between China and India has been growing steadily year by year. As one of the main export destination countries of China's pharmaceutical raw materials, as a part of the whole pharmaceutical raw materials market, it is becoming one of the largest API import markets in the world, and also an important target market for many Chinese API manufacturers. For Chinese pharmaceutical, pharmaceutical packaging, pharmaceutical machinery enterprises, Indonesia will be a market with great development potential.